We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hypothermia May Protect Brain after Cardiac Arrest

By HospiMedica staff writers
Posted on 29 May 2001
A phase I/II trial is seeking to determine whether rapid cooling can protect brain cells from damage in patients who suffer cardiac arrest and are then resuscitated. More...
Prior small studies have shown that hypothermia is effective for this purpose.

After cardiac arrest and cessation of heartbeat, four out of five patients who are unconscious following resuscitation suffer serious brain damage or die. In fact, most suffer some mental decline as a result of no blood flow for only 10 minutes. Researchers believe that hypothermia can slow down the cascade of biochemical events that occurs when the brain is deprived of oxygen as well as the cascade of events that occurs when blood flow is restored to the brain, following resuscitation. Other trials cooled patients from the outside, using special cooling blankets. The current trials will cool patients from the inside-out and will sedate them so they don't shiver.

One site involved in the multicenter trial is Duke University Medical Center (Durham, NC, USA). One of the first patients in the new trial was recently treated there after going into cardiac arrest en route to the hospital. Paramedics shocked his heart back into action, but he went about 10 minutes without blood flow to his brain. He arrived at Duke in a coma.

Within minutes, doctors threaded a triple lumen catheter through a vessel in his leg to his vena cava and began circulating cool saline throughout the catheter. Within several hours, the patient's body had cooled from 37o C to 32o C. After spending 24 hours in the neurologic intensive care unit, he was slowly rewarmed back to normal body temperature. Days later, he received an operation to correct a congenital condition that can cause sudden episodes of extremely fast heart rates, the cause of his cardiac arrest. He was discharged the next day.

"Had he been out for 20 to 30 minutes, there would have been only a 10-20% chance he would have survived,” said Dr. Carmelo Graffagnino, a neurologist at Duke who organized and leads the multicenter trial. "He is now back at work and seems perfectly normal. We hope that the cooling played a role in that, but we won't know for sure until the study is done.”



Related Links:
Duke. Univ.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.